Table 2.
OR from multivariate LR models for PDR, refDR, and DME
| Outcome | β | OR | 95% CI |
|---|---|---|---|
| PDR | |||
| Covariate | |||
| Insulin (0/1) | 1.333 | 3.768 | 3.439–4.129 |
| HgbA1c (%) | 0.150 | 1.162 | 1.140–1.185 |
| Age at visit (years) | −0.030 | 0.966 | 0.964–0.969 |
| Systolic BP (mmHg) | 0.010 | 1.010 | 1.008–1.013 |
| BMI (kg/m2) | −0.020 | 0.975 | 0.969–0.980 |
| Diabetic peripheral neuropathy (0/1) | 0.743 | 2.104 | 1.936–2.286 |
| LDL (mg/dL) | 0.002 | 1.002 | 1.002–1.004 |
| UACR (mg/g) | 0.003 | 1.003 | 1.003–1.004 |
| Serum creatinine (mg/dL) | 0.205 | 1.238 | 1.195–1.263 |
| refDR | |||
| Covariate | |||
| Insulin (0/1) | 1.097 | 2.996 | 2.897–3.098 |
| HgbA1c (%) | 0.251 | 1.285 | 1.275–1.296 |
| Age at visit (years) | −0.222 | 0.978 | 0.977–0.979 |
| Systolic BP (mmHg) | 0.011 | 1.011 | 1.010–1.012 |
| BMI (kg/m2) | −0.023 | 0.976 | 0.975–0.979 |
| Diabetic peripheral neuropathy (0/1) | 0.349 | 1.418 | 1.369–1.468 |
| LDL (mg/dL) | 0.002 | 1.002 | 1.002–1.003 |
| UACR (mg/g) | 0.002 | 1.002 | 1.002–1.003 |
| Serum creatinine (mg/dL) | 0.139 | 1.149 | 1.127–1.172 |
| DME | |||
| Covariate | |||
| Insulin (0/1) | 1.003 | 2.727 | 2.596–2.865 |
| HgbA1c (%) | 0.123 | 1.130 | 1.116–1.145 |
| Age at visit (years) | 0.005 | 1.005 | 1.003–1.006 |
| Systolic BP (mmHg) | 0.009 | 1.009 | 1.007–1.010 |
| BMI (kg/m2) | −0.013 | 0.986 | 0.983–0.990 |
| Diabetic peripheral neuropathy (0/1) | 0.376 | 1.457 | 1.389–1.529 |
| LDL (mg/dL) | 0.004 | 1.004 | 1.004–1.005 |
| UACR (mg/g) | 0.002 | 1.002 | 1.002–1.003 |
| Creatinine (mg/dL) | 0.120 | 1.127 | 1.102–1.154 |
Nonstandardized ORs from multivariate LR models of all nine covariates were calculated for each outcome. The 95% CIs are included. All P values were <0.001. BP, blood pressure; HgbA1c, glycosylated hemoglobin.